{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:33:16Z","timestamp":1786649596556,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pulmonary hypertension (PH) is a rare and usually irreversible disease, eventually leading to right heart failure (RHF). There are multiple PH registries in adults with PH, but very few pediatric PH registries, especially from developing countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>All children (aged 3 months\u201318 years) diagnosed with PH were enrolled in the study. PH was defined by standard echocardiographic and cardiac catheterization criteria. We excluded patients with transient or reversible PH, including hyperkinetic PH associated with congenital heart defects (CHDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our registry included 100 children from June 2019 to January 2024, with an equal gender ratio (male: female = 1:1). Easy fatigability, syncope, and RHF were the most common presenting features. Only 15% of children were classified as idiopathic pulmonary artery hypertension (IPH). The majority (81%) of children belonged to the CHD-pulmonary artery hypertension (CHD-PAH) group (49% Eisenmenger syndrome, 26% CHD with systemic to pulmonary shunt and severe PAH falling in the inoperable category, and 6% had post-operative residual PH). All patients in the IPH group and 42 patients (48.2%) in other PH were on pulmonary vasodilators. The median follow-up duration was 13 months (range: 4\u201356 months). Overall, there were 5 deaths (5% mortality), with 3 deaths in the IPH (20%) group. Children with CHD-PAH had better functional class, and no patient in this group died.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The underlying etiology and prognosis in children with PH may differ in the Indian context compared to the Western world. Different centers across India may still face a higher proportion of unoperated CHD due to late referral, a limited number of specialized centers, and financial constraints. Children with IPH have poor long-term outcomes and a high risk of mortality. Multicenter PH registries may provide actual statistics and further insights into the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/apc.apc_181_24","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:00:10Z","timestamp":1776236410000},"page":"14-22","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric pulmonary hypertension registry: Single-center experience from India"],"prefix":"10.4103","volume":"19","author":[{"given":"Wadile","family":"Santosh","sequence":"first","affiliation":[{"name":"Department of Pediatric Cardiology, Sri Sathya Sai Sanjeevani Centre for Child Heart Care and Training in Pediatric Cardiac Skills, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishra","family":"Arpita","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Sri Sathya Sai Sanjeevani Centre for Child Heart Care and Training in Pediatric Cardiac Skills, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banpurkar Ashishkumar","family":"Moreshwar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Sri Sathya Sai Sanjeevani Centre for Child Heart Care and Training in Pediatric Cardiac Skills, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raeen Shahena","family":"Parveen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Sri Sathya Sai Sanjeevani Centre for Child Heart Care and Training in Pediatric Cardiac Skills, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulkarni","family":"Snehal","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Sri Sathya Sai Sanjeevani Centre for Child Heart Care and Training in Pediatric Cardiac Skills, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","article-title":"Clinical features of paediatric pulmonary hypertension: A registry study","volume":"379","author":"Berger","year":"2012","journal-title":"Lancet"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1183\/09031936.00056110","article-title":"Pulmonary arterial hypertension: A comparison between children and adults","volume":"37","author":"Barst","year":"2011","journal-title":"Eur Respir J"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.111.026591","article-title":"Survival in childhood pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2008.150086","article-title":"Treatment and survival in children with pulmonary arterial hypertension: The UK pulmonary hypertension service for children 2001-2006","volume":"95","author":"Haworth","year":"2009","journal-title":"Heart"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.202110-2428OC","article-title":"Twenty-year experience and outcomes in a national pediatric pulmonary hypertension service","volume":"206","author":"Constantine","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjcard.2010.02.023","article-title":"Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies","volume":"106","author":"van Loon","year":"2010","journal-title":"Am J Cardiol"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2014.02.575","article-title":"Survival differences in pediatric pulmonary arterial hypertension: Clues to a better understanding of outcome and optimal treatment strategies","volume":"63","author":"Zijlstra","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ppedcard.2009.09.002","article-title":"Towards improving the care of children with pulmonary hypertension: The rationale for developing a pediatric pulmonary hypertension network","volume":"27","author":"Abman","year":"2009","journal-title":"Prog Pediatr Cardiol"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ihj.2021.01.007","article-title":"Potts shunt as an effective palliation for patients with end stage pulmonary arterial hypertension","volume":"73","author":"Bobhate","year":"2021","journal-title":"Indian Heart J"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"2045894021989966","DOI":"10.1177\/2045894021989966","article-title":"Study of the effect of occlutech atrial flow regulator on symptoms, hemodynamics, and echocardiographic parameters in advanced pulmonary arterial hypertension","volume":"11","author":"Sivakumar","year":"2021","journal-title":"Pulm Circ"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: Epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"190050","DOI":"10.1183\/16000617.0050-2019","article-title":"Learning from registries in pulmonary arterial hypertension: Pitfalls and recommendations","volume":"28","author":"Swinnen","year":"2019","journal-title":"Eur Respir Rev"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/jcm9061717","article-title":"Children and adolescents with pulmonary arterial hypertension: Baseline and follow-up data from the Polish registry of pulmonary hypertension (BNP-PL)","volume":"9","author":"Kwiatkowska","year":"2020","journal-title":"J Clin Med"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/CIRCULATIONAHA.110.969584","article-title":"Pediatric pulmonary hypertension in the Netherlands: Epidemiology and characterization during the period 1991 to 2005","volume":"124","author":"van Loon","year":"2011","journal-title":"Circulation"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpeds.2009.02.036","article-title":"Clinical characterization of pediatric pulmonary hypertension: Complex presentation and diagnosis","volume":"155","author":"van Loon","year":"2009","journal-title":"J Pediatr"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"e12180","DOI":"10.1002\/pul2.12180","article-title":"Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension","volume":"12","author":"Kumar","year":"2022","journal-title":"Pulm Circ"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"2003337","DOI":"10.1183\/13993003.03337-2020","article-title":"Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet registry","volume":"59","author":"Abman","year":"2022","journal-title":"Eur Respir J"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jacc.2022.01.022","article-title":"Eisenmenger syndrome: JACC state-of-the-art review","volume":"79","author":"Arvanitaki","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"e892","DOI":"10.1542\/peds.2006-3411","article-title":"Pulmonary hypertension in patients with congenital portosystemic venous shunt: A previously unrecognized association","volume":"121","author":"Ohno","year":"2008","journal-title":"Pediatrics"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S1047951123004006","article-title":"Trans-catheter closure of an unusual type of Abernethy malformation in a child presenting with severe pulmonary hypertension","volume":"34","author":"Wadile","year":"2024","journal-title":"Cardiol Young"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ihj.2020.12.015","article-title":"Congenital extrahepatic portocaval malformation: Rare but potentially treatable cause of pulmonary hypertension","volume":"73","author":"Bobhate","year":"2021","journal-title":"Indian Heart J"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/apc.apc_5_22","article-title":"Transcatheter closure of congenital portosystemic shunts \u2013 A multicenter experience","volume":"15","author":"Koneti","year":"2022","journal-title":"Ann Pediatr Cardiol"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/ehjqcco\/qcad020","article-title":"Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: Results from the global TOPP registry","volume":"10","author":"Ploegstra","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["Annals of Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_181_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:55:50Z","timestamp":1786647350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_181_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/apc.apc_181_24","relation":{},"ISSN":["0974-2069","0974-5149"],"issn-type":[{"value":"0974-2069","type":"print"},{"value":"0974-5149","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2024-10-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}